Efficacy and safety of gemigliptin as add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus (ZEUS II study).
Cho YM, Deerochanawong C, Seekaew S, Suraamornkul S, Benjachareonwong S, Sattanon S, Chamnan P, Sirirak T, Kosachunhanun N, Pratipanawatr T, Suwanwalaikorn S, Lee WJ, Kim S, Choi S, Kang ES, Oh T, Kwon S, Lee MK.
Cho YM, et al. Among authors: pratipanawatr t.
Diabetes Obes Metab. 2020 Jan;22(1):123-127. doi: 10.1111/dom.13873. Epub 2019 Oct 8.
Diabetes Obes Metab. 2020.
PMID: 31478335
Clinical Trial.